Vol. 2, 2017

Original research papers



Vesna Stojiljković , Ljubica Gavrilović, Snežana Pejić, Ana Todorović, Nataša Popović, Ivan Pavlović, Snežana B. Pajović

Pages: 237-242

DOI: 10.21175/RadProc.2017.49

Celiac disease (CD) is an autoimmune disorder provoked by wheat gluten and related proteins from other grains. The only treatment for the patients is a lifelong gluten free diet (GFD). Oxidative stress has been implicated in the pathogenesis of CD. The aim of this study was to examine the modulation of the biochemical response to oxidative stress in children affected by CD. Study involved peripheral blood samples and small intestinal biopsies from 69 children diagnosed with CD. According to the histological findings, patients were divided into following groups: Marsh 0: normal mucosa with no signs of inflammation (n=31); Marsh 1: mucosa was characterized by intraepithelial lymphocytosis (n=5); Marsh 2: intraepithelial lymphocytosis was accompanied by crypt hyperplasia (n=4); Marsh 3a: mucosa showed partial villous atrophy (n=20); Marsh 3b: subtotal villous atrophy was present (n=9). For the statistical purposes groups Marsh 1 and Marsh 2 were treated as one (Marsh 1+2, n=9). The activities and protein levels of copper, zinc superoxide dismutase (CuZnSOD) and manganese SOD (MnSOD), as well as the concentrations of lipid hydroperoxides (LOOH) were determined in intestinal biopsies, while in the peripheral blood, MnSOD activity was not measured, due to the methodological obstacles. CuZnSOD activity in the blood varied significantly between the analyzed groups. Marsh 3a and Marsh 3b had increased CuZnSOD activity comparing to the Marsh 0 (P < 0.05). LOOH concentration also varied significantly. LOOH level was higher in the blood of Marsh 3a (P < 0.001) and Marsh 3b (P < 0.05), than in Marsh 0. In the biopsy samples, MnSOD activity and LOOH concentration showed significant differences between the groups, while no significant difference was found for CuZnSOD activity. In comparison to Marsh 0, MnSOD activity was significantly elevated in Marsh 3a (P < 0.01). Significant increase in LOOH concentration was found in Marsh 3a (P < 0.001) and Marsh 3b (P < 0.01), comparing to Marsh 0. In addition, Marsh 3a group had higher LOOH concentration than Marsh 1+2. Relative MnSOD and CuZnSOD protein level in peripheral blood and intestinal mucosa did not vary significantly between the analyzed groups. Positive correlations were found between the severity of mucosal lesion and CuZnSOD activity (P < 0.001), as well as LOOH concentration (P < 0.001) in peripheral blood. Similar correlations were found also in intestinal mucosa: MnSOD: P < 0.05; CuZnSOD: P < 0.05; LOOH: P < 0.001. Our results show that oxidant/antioxidant balance is disturbed in CD patients with mucosal lesions. An increase in SOD activity as a consequence of oxidant pressure, is not enough to maintain the normal level of free radicals, which leads to enhanced lipid peroxidation. These processes persist even in some patients on a long-term GFD.
  1. C. Catassi, E. Fabiani, “The spectrum of coeliac disease in children,” Bailliere’s Clin. Gastroenterol., vol. 11, no. 3, pp. 485-507, Sep. 1997.
    DOI: 10.1016/S0950-3528(97)90028-2
  2. R. J. Farrell, C. P. Kelly, “Celiac sprue,” N. Engl. J. Med., vol. 346, no. 3, pp. 180-188, Jan. 2002.
    DOI: 10.1056/NEJMra010852
    PMid: 11796853
  3. B. Dugas, P. Debre, S. Moncada, “Nitric oxide, a vital poison inside the immune and inflammatory network,” Res. Immunol,vol. 146, no. 9, pp. 664-670, Nov-Dec. 1995.
    DOI: 10.1016/0923-2494(96)84914-5
  4. P. Odetti et al., “Oxidative stress in subjects affected by celiac disease,” Free Radic. Res., vol. 29, no. 1, pp. 17-24, Jul. 1998.
    DOI: 10.1080/10715769800300031
    PMid: 9733018
  5. V. Stojiljkovic et al., “Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease,” Ann. Clin. Biochem.,vol. 44, no. 6, pp. 537-543, Nov. 2007.
    Retrieved from: http://journals.sagepub.com/doi/pdf/10.1258/000456307782268075
    Retrieved on: Dec. 15, 2016
  6. V. Stojiljkovic et al., “Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease,” Clin. Biochem.,vol. 42, no. 13-14, pp. 1431-1437, Sep. 2009.
    DOI: 10.1016/j.clinbiochem.2009.06.009
    PMid: 19560448
  7. J. A. Walker-Smith, “Revised criteria for diagnosis of coeliac disease, Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition,” Arch. Dis. Child., vol. 65, no. 8, pp. 909-911, Aug. 1990.
    DOI: 10.1136/adc.65.8.909
  8. G. Oberhuber, G. Granditsch, H. Vogelsang, “The histopathology of coeliac disease: time for a standardized report scheme for pathologists,” Eur. J. Gastroenterol. Hepatol.,vol. 11, no. 10, pp. 1185-1194, Oct. 1999.
    DOI: 10.1097/00042737-199910000-00019
    PMid: 10524652
  9. M. Valko et al., “Free radicals and antioxidants in normal physiological functions and human disease,” Int. J. Biochem. Cell Biol., vol. 39, no. 1, pp. 44–84, 2007.
    DOI: 10.1016/j.biocel.2006.07.001
    PMid: 16978905
  10. D. T. Sawyer, “Superoxide Chemistry,” AccessScience, 2014.
    DOI: 10.1036/1097-8542.669650
  11. M. Boda, I. Németh and D. Boda, “The caffeine metabolic ratio as an index of xanthine oxidase activity in clinically active and silent celiac patients,” J. Pediatr. Gastroenterol. Nutr., vol. 29, no. 5, pp. 546–550, Nov. 1999.
    DOI: 10.1097/00005176-199911000-00014
    PMid: 10554121
  12. F. Yamakura and H. Kawasaki, “Post-translational modifications of superoxide dismutase,” Biochim. Biophys. Acta., vol. 1804, no. 2, pp. 318-325, Feb. 2010.
    DOI: 10.1016/j.bbapap.2009.10.010
    PMid: 19837190
  13. Y. Furukawa, A. S. Torres, T. V. O`Halloran, “Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS,” EMBO J., vol. 23, no. 14, pp. 2872-2881, Jul. 2004.
    DOI: 10.1038/sj.emboj.7600276
    PMid: 15215895
    PMCid: PMC1150991
  14. T. Y. Aw, “Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine,” Am. J. Clin. Nutr.,vol. 70, no. 4, pp. 557–565, Oct. 1999.
    Retrieved from: http://ajcn.nutrition.org/content/70/4/557.full.pdf+html
    Retrieved on: Dec. 11, 2016
  15. R. Rivabene, E. Mancini, M. De Vincenzi, “In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease,” Biochim. Biophys. Acta, vol. 1453, no. 1, pp. 152–160, Jan. 1999.
    DOI: 10.1016/S0925-4439(98)00095-7